Navigation Links
Advanced Life Sciences Announces Third Quarter 2009 Financial Results
Date:11/10/2009

ents or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements represent our management's judgment regarding future events. The Company does not undertake any obligations to update any forward-looking statements whether as a result of new information, future events or otherwise. Our actual results could differ materially from those discussed herein due to several factors including the success and timing of our clinical trials, the adequacy of our clinical results, the timing and terms of any commercial partnership, and our ability to obtain and maintain regulatory approval and labeling of our product candidates; our plans to develop and commercialize our product candidates; the loss of key scientific or management personnel; the size and growth of potential markets for our product candidates and our ability to serve those markets; regulatory developments in the U.S. and foreign countries; the rate and degree of market acceptance of any future products; the accuracy of our estimates regarding expenses, future revenues and capital requirements; our ability to obtain financing on terms acceptable to us; our ability to obtain and maintain intellectual property protection for our product candidates; the successful development of our sales and marketing capabilities; the success of competing drugs that become available; and the performance of third party collaborators and manufacturers. These and additional risks and uncertainties are detailed in the Company's filings with the Securities and Exchange Commission.

    ADVANCED LIFE SCIENCES HOLDINGS, INC. AND SUBSIDIARY
    (A Development Stage Company)


    CONSOLIDATED BALANCE SHEETS                September 30,  December 31,
    (Unaudited)                                     2009          2008
    ----------                                  -----------    ----------

    ASSETS

    CURRENT ASSETS:
      Cash and ca
'/>"/>
SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Boston Scientifics Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan
2. Free 2D/3D Advanced Visualization Software for CT and MRI Now Available From FiatLux Imaging
3. Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal
4. Healthcare Industry Celebrates 25 Years of Advanced Pain Management With PCA Infusion System
5. Lumenis Introduces Advanced Retinal Laser Delivery Technology at the 2009 American Academy of Ophthalmology Annual Meeting in San Francisco, California, USA
6. Advanced Health Media Named to Deloittes 2009 Technology Fast 500(TM)
7. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
8. FDA approves GlaxoSmithKlines VOTRIENT(TM) for advanced renal cell cancer
9. FDA Approves New Treatment for Advanced Form of Kidney Cancer
10. Verathon Introduces the GlideScope(R) Cobalt Advanced Video Laryngoscope (AVL); New Digital Technology Facilitates Quick Intubations
11. New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In-Hospital Emergency Personnel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- Pharmavite LLC announced that Timothy "Tim" Toll has ... Toll recently served as Pharmavite,s executive vice president of ... label and sales administration in the United ... will expand his responsibilities to include international sales, global ... to chief customer officer is part of a plan ...
(Date:7/23/2014)... 23, 2014 /PRNewswire-iReach/ -- The Centers for Medicare & ... Innovation Network-Quality Improvement Organization (QIN-QIO) contract to a partnership ... Effective August 1, WVMI will launch Quality Insights ... , Pennsylvania , Delaware ... Louisiana.  The Network will engage providers and the community ...
(Date:7/23/2014)... /PRNewswire-iReach/ -- Use of Risk Evaluation and Mitigation Strategies ... market entry results in $5.4 billion in lost savings ... by economic consulting firm Matrix Global Advisors ... Required by the Food and Drug Administration ... are intended to improve drug safety by ensuring that ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2New Analysis Finds $5.4 Billion In Annual Lost Savings From Strategies Geared Toward Delaying Generic Drug Entry 2
... Texas, July 14, 2011 Convergen LifeSciences ... 7,977,468 has been awarded by the U.S. Patent and ... Board of Regents and The Secretary, U.S. Department of ... of 23 patents, pending or issued worldwide, licensed exclusively to ...
... REDWOOD CITY, Calif., July 14, 2011 Codexis, Inc. (Nasdaq: ... in the 13th Annual Pacific Crest Global Technology Leadership Forum, ... Robert Lawson, Senior Vice President and Chief Financial Officer, will ... Biofuels and Renewable Chemicals," scheduled for August 8 at 12:30 ...
Cached Medicine Technology:Convergen LifeSciences Announces Patent Award 2
(Date:7/23/2014)... Greenville, SC (PRWEB) July 23, 2014 AidJoy ... celebration of philanthropy at Zen on September 5, ... business community and AidJoy supporters are expected to attend this ... of our triumphs of the past six years," says Jess ... time to pause to reflect on this moment in AidJoy’s ...
(Date:7/23/2014)... "I wanted a better way to keep track of all ... pressure and pulse rate," said an inventor from Long Beach, ... a bunch of different devices, so I invented one that ... to make it easier to monitor health conditions. The invention ... enables the user to have more control over his or ...
(Date:7/23/2014)... athletes who suffered repeated blows to the head during ... Those clumps suggest the athletes had a disease called ... tests that might be able to detect CTE in ... Chemical & Engineering News (C&EN) , the weekly news ... article, Lauren Wolf, a senior editor at C&EN, explains ...
(Date:7/23/2014)... The Centers for Disease Control and Prevention applauded ... 2010 to 2012. Formerly known as “the nation’s medicine ... to some of the strongest opiates, such as Oxycontin, which ... launched an initiative to crack down on these rampant pill ... that existed in the state just a few years ago. ...
(Date:7/23/2014)... Fla. (PRWEB) July 23, 2014 ... results from leading academic institutions uncovering the importance ... opinions surrounding the need for breast self-exams is ... there is proof today for keeping this healthy ... cases mislead about the significance of breast self-exams ...
Breaking Medicine News(10 mins):Health News:AidJoy’s Inaugural Gala to be Held September 5, 2014 2Health News:Florida’s Crackdown on Pill Mills Has Led to Rise in Popularity of Synthetic Drugs; Suncoast Rehab Educates on Dangers of These Drugs in Adolescents 2Health News:Florida’s Crackdown on Pill Mills Has Led to Rise in Popularity of Synthetic Drugs; Suncoast Rehab Educates on Dangers of These Drugs in Adolescents 3Health News:Florida’s Crackdown on Pill Mills Has Led to Rise in Popularity of Synthetic Drugs; Suncoast Rehab Educates on Dangers of These Drugs in Adolescents 4Health News:Historical and Current Research Points to Importance of Breast Self-Exams 2
... for New York Blood Center (NYBC), NEW YORK, ... a blood drive on Monday, June 2 at 1011 ... School Gymnasium. Hours are from,9:30am-3:00pm, The Archdiocese of ... York,Blood Center; His Eminence Edward Cardinal Egan serves as ...
... WASHINGTON, May 30 The Department of,Veterans Affairs (VA) ... identified as being ill or injured from Operation,Enduring Freedom ... over 500,000 OEF-OIF veterans who have been,discharged from active ... "We promised to reach out to every OEF ...
... whole milk is just as effective, costs less and is ... is also commonly used as an oral contrast agent in conjunction ... , The study included 215 patients undergoing abdominal and pelvic CT, ... patients were given an IV contrast media; 115 were also given ...
... Results from a pivotal Phase III clinical ... once-daily, investigational anticoagulant medication, was superior in preventing ... knee replacement (TKR) surgery. The head-to-head study compared ... the current standard of care. , Data from ...
... May 30 Insulet Corporation,(Nasdaq: PODD ), ... its,OmniPod(R) Insulin Management System, today announced the company ... Obesity Conference.,Management is scheduled to present an overview ... June 6, 2008 at The Hotel Nikko in ...
... New Video ,Milestones in Oncology, Presentations at ... Society for Translational Oncology,(STO) is pleased to announce ... valuable video presentations for practicing,oncologists., (Logo: ... on the occasion of the 2008 Annual Meeting ...
Cached Medicine News:Health News:New York's Catholic Archdiocese Hosting June 2 Blood Drive 2Health News:VA Begins Next Phase of Combat Vet Outreach 2Health News:Rivaroxaban phase III pivotal data presented at EFORT annual meeting 2Health News:Rivaroxaban phase III pivotal data presented at EFORT annual meeting 3Health News:Society for Translational Oncology Launches Updated Website 2
... The SleepStyle 200 series offers a ... CPAP models. The design delivers therapy ... Performance features promote results in commercial ... The strongest differentiator in the SleepStyle ...
... The SleepStyle 200 series offers a ... CPAP models. The design delivers therapy ... Performance features promote results in commercial ... The strongest differentiator in the SleepStyle ...
The SleepStyle 600 series with ThermoSmart delivers humidification with anti-rainout benefits. ThermoSmart technology offers a heated breathing tube that allows the constant delivery of optimal level...
The S7 Lightweight offers the comfort and reliability of the award-winning S7 series in a convenient, affordable device....
Medicine Products: